2024-01-22 11:37:28 ET
Summary
- LifeMD, Inc.'s newly issued 2024 guidance indicates an impressive 38% CAGR, positioning it as an attractive investment opportunity.
- With a valuation priced at less than 11x forward EBITDA, LifeMD stock is considered advantageous, although investor skepticism persists regarding the sustainability of such growth rates in a competitive market.
- Despite concerns about the program's long-term sustainability, I believe the stock offers a favorable risk-reward scenario.
Investment Thesis
LifeMD, Inc. ( LFMD ) is a telehealth company that provides online healthcare services, specializing in men's health and weight management. Recently, their prospects have gained traction on the back of their success in the GLP-1 weight management program....
Read the full article on Seeking Alpha
For further details see:
LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability